Koninklijke Philips Retained Earnings (Accumulated Deficit) 2010-2024 | PHG

Koninklijke Philips retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Koninklijke Philips retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $4.019B, a 54.14% decline year-over-year.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2024 were $3.95B, a 32.44% decline from 2023.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2023 were $5.847B, a 18.78% decline from 2022.
  • Koninklijke Philips retained earnings (accumulated deficit) for 2022 were $7.198B, a 34.89% decline from 2021.
Koninklijke Philips Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $3,950
2023 $5,847
2022 $7,198
2021 $11,055
2020 $8,942
2019 $9,292
2018 $9,762
2017 $9,716
2016 $9,111
2015 $8,928
2014 $11,685
2013 $13,834
2012 $13,778
2011 $17,991
2010 $20,587
2009 $22,240
Koninklijke Philips Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $4,019
2023-06-30 $5,831
2023-03-31
2022-06-30 $8,566
2021-06-30 $8,764
2020-06-30 $7,392
2019-06-30
2018-06-30 $9,535
2017-06-30 $9,153
2016-12-31 $9,111
2016-09-30 $9,058
2016-06-30 $8,806
2016-03-31 $8,816
2015-12-31 $8,928
2015-09-30 $9,524
2015-06-30 $9,121
2015-03-31 $9,834
2014-12-31 $11,685
2014-09-30 $12,675
2014-06-30 $13,308
2014-03-31 $14,111
2013-12-31 $13,834
2013-09-30 $13,122
2013-06-30 $13,619
2013-03-31 $14,334
2012-12-31 $13,778
2012-09-30 $14,181
2012-06-30 $16,011
2012-03-31 $17,174
2011-12-31 $17,991
2011-09-30 $19,146
2011-06-30 $19,419
2011-03-31 $20,293
2010-12-31 $20,587
2010-09-30 $21,041
2010-06-30 $20,122
2010-03-31 $21,507
2009-12-31 $22,240
2009-09-30 $21,204
2009-06-30 $19,961
2009-03-31 $21,467
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.420B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.047B 28.90
Boston Scientific (BSX) United States $154.056B 41.59
Stryker (SYK) United States $148.022B 31.82
EssilorLuxottica (ESLOY) France $137.298B 0.00
Medtronic (MDT) Ireland $115.624B 16.89
Lonza Group Ag (LZAGY) Switzerland $46.792B 0.00
Haleon (HLN) United Kingdom $45.950B 29.85
GE HealthCare Technologies (GEHC) United States $41.418B 20.17
Agilent Technologies (A) United States $38.594B 25.57
ResMed (RMD) United States $33.728B 25.98
Terumo (TRUMY) Japan $25.984B 36.95
Zimmer Biomet Holdings (ZBH) United States $21.098B 13.25
Insulet (PODD) United States $19.908B 85.13
Baxter (BAX) United States $17.948B 12.94
Smith & Nephew SNATS (SNN) United Kingdom $11.490B 0.00
Sunny Optical Technology (SNPTF) China $11.331B 0.00
BellRing Brands (BRBR) United States $9.348B 35.03
Demant (WILYY) Denmark $8.092B 0.00
Bio-Rad Laboratories (BIO) United States $7.847B 27.17
Lantheus Holdings (LNTH) United States $5.489B 12.75
Prestige Consumer Healthcare (PBH) United States $4.215B 20.11
ICU Medical (ICUI) United States $3.924B 37.35
Envista Holdings (NVST) United States $3.683B 29.30
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.312B 15.58
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.850B 19.20
QuidelOrtho (QDEL) United States $2.822B 23.71
LeMaitre Vascular (LMAT) United States $2.294B 55.75
Neogen (NEOG) United States $2.261B 26.05
AtriCure (ATRC) United States $1.916B 0.00
Green Thumb Industries (GTBIF) United States $1.494B 26.06
InMode (INMD) Israel $1.330B 11.12
BioLife Solutions (BLFS) United States $1.193B 0.00
AdaptHealth (AHCO) United States $1.150B 8.22
Maravai LifeSciences Holdings (MRVI) United States $1.013B 0.00
Curaleaf Holdings (CURLF) Canada $0.920B 0.00
CeriBell (CBLL) United States $0.911B 0.00
Phibro Animal Health (PAHC) United States $0.896B 13.74
Evolus (EOLS) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.657B 0.00
Valneva SE (VALN) France $0.635B 0.00
VAREX IMAGING (VREX) United States $0.538B 23.32
Omeros (OMER) United States $0.503B 0.00
Surmodics (SRDX) United States $0.501B 0.00
Owens & Minor (OMI) United States $0.493B 3.85
SNDL (SNDL) Canada $0.439B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.349B 0.00
Quanterix (QTRX) United States $0.311B 0.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Aurora Cannabis (ACB) Canada $0.308B 56.10
Cerus (CERS) United States $0.305B 0.00
Viemed Healthcare (VMD) United States $0.300B 28.52
OraSure Technologies (OSUR) United States $0.298B 19.95
Biote (BTMD) United States $0.252B 5.52
Canopy Growth (CGC) Canada $0.252B 0.00
Zynex (ZYXI) United States $0.234B 49.07
Sanuwave Health (SNWV) United States $0.231B 3.24
High Tide (HITI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.204B 15.21
Brainsway (BWAY) Israel $0.184B 97.80
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
MacroGenics (MGNX) United States $0.166B 0.00
TerrAscend (TSNDF) Canada $0.164B 0.00
Organigram Holdings (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.137B 17.17
Jin Medical (ZJYL) China $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.092B 12.92
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.083B 0.00
InterCure (INCR) Israel $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
Exagen (XGN) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.057B 29.17
Apyx Medical (APYX) United States $0.054B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.046B 13.24
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.042B 0.00
INLIF (INLF) $0.032B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00